Samrat Pharmachem standalone net profit declines 4.00% in the September 2020 quarter
Sales rise 13.57% to Rs 41.50 crore
Net profit of Samrat Pharmachem declined 4.00% to Rs 1.44 crore in the quarter ended September 2020 as against Rs 1.50 crore during the previous quarter ended September 2019. Sales rose 13.57% to Rs 41.50 crore in the quarter ended September 2020 as against Rs 36.54 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales41.5036.54 14 OPM %6.435.67 -PBDT2.412.26 7 PBT2.292.15 7 NP1.441.50 -4Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content